<SEC-DOCUMENT>0001213900-15-003200-index.html : 20150501 <SEC-HEADER>0001213900-15-003200.hdr.sgml : 20150501 <ACCEPTANCE-DATETIME>20150501161239 ACCESSION NUMBER: 0001213900-15-003200 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT: 4 FILED AS OF DATE: 20150501 DATE AS OF CHANGE: 20150501 EFFECTIVENESS DATE: 20150501 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SOLIGENIX, INC. CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEFA14A SEC ACT: 1934 Act SEC FILE NUMBER: 000-16929 FILM NUMBER: 15824472 BUSINESS ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE C-10 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-538-8200 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE C-10 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DOR BIOPHARMA INC DATE OF NAME CHANGE: 20020329 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 </SEC-HEADER> <DOCUMENT> <TYPE>DEFA14A <SEQUENCE>1 <FILENAME>defa14a0415_soligenix.htm <DESCRIPTION>SCHEDULE 14A PROXY STATEMENT <TEXT> Document 1 - file: defa14a0415_soligenix.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>2 <FILENAME>image_001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 2 - file: image_001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>image_002.gif <DESCRIPTION>GRAPHIC <TEXT> Document 3 - file: image_002.gif
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>image_003.gif <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: image_003.gif
</DOCUMENT> </SEC-DOCUMENT>